Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Retour au sujet CRUCELL

CRUCELL : Greed is Goudsmit

20 févr. 200918:11


February 19, 2009 8:51 AM EST
Shares of Crucell NV (Nasdaq: CRXL) are seeing pressure in early trading today following a disclosure that CEO Ronald Brus and Chief Scientific Officer Jaap Goudsmit sold about $4.8 million of stock recently.

According to Bloomberg, Brus exercised 250,000 options expiring in April at a strike price of 9.4 euros, according to a filing posted on the website of the Dutch market regulator AFM. He sold 165,000 shares at 15.73 euros apiece. Goudsmit exercised 85,000 options expiring in April at a strike price of 9.4 euros and sold 75,000 shares at the same price, the filing shows.

The selling in Crucell might be exaggerated as the insider selling could kill buyout speculation on the name. Recently, Wyeth (NYSE: WYE) ended takeover talks with Crucell NV after it was bought by Pfizer (NYSE: PFE), but many expected other bidders to look at Crucell NV.

Shares of Crucell NV are down 6.8% this AM.

Donc il ne se passera rien avant avril. On s'en doutait un peu

0 réponse

Retour au sujet CRUCELL

Mes listes

Cette liste ne contient aucune valeur.